(NASDAQ: ATAI) Atai Beckley Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.
Atai Beckley Nv's earnings in 2026 is -$154,192,000.On average, 14 Wall Street analysts forecast ATAI's earnings for 2026 to be -$177,963,356, with the lowest ATAI earnings forecast at -$352,367,444, and the highest ATAI earnings forecast at -$114,405,014. On average, 11 Wall Street analysts forecast ATAI's earnings for 2027 to be -$186,498,333, with the lowest ATAI earnings forecast at -$306,096,972, and the highest ATAI earnings forecast at -$141,099,518.
In 2028, ATAI is forecast to generate -$132,637,179 in earnings, with the lowest earnings forecast at -$142,370,685 and the highest earnings forecast at -$114,405,014.